Two Sigma Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,005
| Closed | -$5.48M | – | 3134 |
|
|
2025
Q1 | $5.48M | Buy |
+47,005
| New | +$5.48M | 0.01% | 1044 |
|
|
2022
Q4 | – | Sell |
-141,312
| Closed | -$6.31M | – | 2741 |
|
|
2022
Q3 | $6.31M | Buy |
+141,312
| New | +$6.31M | 0.02% | 642 |
|
|
2022
Q2 | – | Sell |
-52,874
| Closed | -$2.19M | – | 2439 |
|
|
2022
Q1 | $2.19M | Sell |
52,874
-39,696
| -43% | -$1.64M | 0.01% | 1276 |
|
|
2021
Q4 | $3.5M | Buy |
92,570
+71,370
| +337% | +$2.7M | 0.01% | 1066 |
|
|
2021
Q3 | $699K | Buy |
+21,200
| New | +$699K | ﹤0.01% | 1869 |
|
|
2021
Q2 | – | Sell |
-161,801
| Closed | -$9.16M | – | 2421 |
|
|
2021
Q1 | $9.16M | Buy |
161,801
+145,901
| +918% | +$8.26M | 0.02% | 606 |
|
|
2020
Q4 | $1.3M | Buy |
+15,900
| New | +$1.3M | ﹤0.01% | 1246 |
|